Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatih Kilic

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Obstetrics and Gynaecology Research|October 19, 2023
Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinomaFatih Kilic, Burak Ersak, Caner Cakir, et al.
Journal of Gynecology Obstetrics and Human Reproduction|January 16, 2021
The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish studyCaner Cakir, Fatih Kilic, Cigdem Kilic, et al.
BMC Women'S Health|June 22, 2024
The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancersAysun Alci, Okan Aytekin, Burak Ersak, et al.
World Journal of Surgical Oncology|December 20, 2024
Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?Abdurrahman Alp Tokalioglu, Okan Oktar, Mehmet Unsal, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|December 12, 2022
Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric studyMehmet Unsal, Cigdem Kilic, Caner Cakir, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 11, 2024
Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?Mustafa Gökkaya, Aysun Alcı, Okan Aytekin, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 26, 2022
Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smearsOkan Aytekin, Caner Cakir, Mehmet Unsal, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in TurkeyYesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin, et al.
Oncology Letters|May 8, 2025
Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapyAbdurrahman Alp Tokalioglu, Okan Oktar, Okan Aytekin, et al.
Asia-Pacific Journal of Clinical Oncology|April 25, 2023
Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish studyOzgur Erdogan, Cigdem Kilic, Caner Cakir, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Obstetrics and Gynaecology Research|October 19, 2023
Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinomaFatih Kilic, Burak Ersak, Caner Cakir, et al.
Journal of Gynecology Obstetrics and Human Reproduction|January 16, 2021
The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish studyCaner Cakir, Fatih Kilic, Cigdem Kilic, et al.
BMC Women'S Health|June 22, 2024
The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancersAysun Alci, Okan Aytekin, Burak Ersak, et al.
World Journal of Surgical Oncology|December 20, 2024
Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?Abdurrahman Alp Tokalioglu, Okan Oktar, Mehmet Unsal, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|December 12, 2022
Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric studyMehmet Unsal, Cigdem Kilic, Caner Cakir, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 11, 2024
Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?Mustafa Gökkaya, Aysun Alcı, Okan Aytekin, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 26, 2022
Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smearsOkan Aytekin, Caner Cakir, Mehmet Unsal, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in TurkeyYesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin, et al.
Oncology Letters|May 8, 2025
Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapyAbdurrahman Alp Tokalioglu, Okan Oktar, Okan Aytekin, et al.
Asia-Pacific Journal of Clinical Oncology|April 25, 2023
Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish studyOzgur Erdogan, Cigdem Kilic, Caner Cakir, et al.
Pageof 5